Now’s the time to update the Spigelman classification!
At #CGAIGC25, @AlexMannucci presented our seminal SRMA on the limitations and our approach to improve it with the DRACO study (NCT07199127)
Promising results with game-changing implications!
@MyUniSR@IstTumori
Attending #DDW2023 ?
Be sure to touch base with @CavestroGM who will be giving a poster presentation
➡️Sun, May 07
➡️12:30pm-1:30pm CST
➡️Delphi initiative for #eoCRC#DIRECt int'l management guidelines
���See our #eoCRC toolkit 🔗https://t.co/dKcguHQ0q2
#HereditaryGICancer
A novel “two-in-one hit�� mechanism, for up to 40% of all
CRC in MLH1 LS.
A “two-in-one hit” model of shortcut carcinogenesis in MLH1 Lynch syndrome carriers https://t.co/17jnqYz5m1
The personal & societal loss of #eoCRC is huge. Often there is a #familial aspect
We encourage the multidisciplinary HC team to use evidence-based guidelines developed by #DIRECt when treating individuals with #eoCRC 🔗https://t.co/CWUYB8zcWO
#MyCRCMoonshot#HereditaryGICancer
👏An example of a fabulous #HereditaryGICancer community collaboration
��Watch this space for an exciting interview & more during the 2023 #ColorectalCancerAwarenessWeek
➡️Learn more abt this collaboration & the DIRECt meeting in Milan earlier this year https://t.co/l2ozeu4LoO
@CGAIGC The best three scientific days of the year🤠. Great science, excellent presentations and friendships. Thank you #CGAIGC22@swatigp . Now it’s up to you @DocStanich , keep up the good work!! Exciting🙌
Massive shoutouts to @swatigp! Great meeting, wonderful talks, always at the cutting edge of knowledge here at @CGAIGC! Science moving forward🙌
#CGAIGC22